Home > Insider Trading > Filing (0001140361-15-036953)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1527599	Mirna Therapeutics Inc.	MIRN	Pharmaceutical Preparations (2834)	261824804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1202793	Michael Powell	C/O Mirna Therapeutics, Inc. 2150 Woodward St., Suite 100 Austin TX 78744		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-10-05	1,244,269	$0.00	1,244,269	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2015-10-05	583,559	$0.00	1,827,828	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2015-10-06	289,841	$0.00	2,117,669	No	4	J	Indirect	See Footnote
Common Stock	Acquisiton	2015-10-06	857,142	$7.00	2,974,811	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C Preferred Stock	Disposition	2015-10-05	1,244,269	$0.00	1,244,269	$0.00
Common Stock	Series D Preferred Stock	Disposition	2015-10-05	583,559	$0.00	583,559	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Each share of Series C and Series D Preferred Stock automatically converted on a one-to-one basis into Common Stock upon the consummation of the Issuer's initial public offering.
The shares are held by Sofinnova Venture Partners VIII, L.P. ("SVP VIII"). Sofinnova Management VIII, L.L.C. ("SM VIII") is the general partner of SVP VIII. The individual Managers, or the Managing Members, of SM VIII are Michael Powell, James Healy, Srinivas Akkaraju and Anand Mehra. The Managers share voting and dispositive power with regard to the shares held directly by SVP VIII. Such persons and entities disclaim beneficial ownership over the shares owned by SVP VIII except to the extent of any pecuniary interest therein.
The shares were issued for no additional consideration pursuant to an accruing paid-in-kind dividend on shares of Series C and Series D Preferred Stock of the Company.
The expiration date is not relevant to the conversion of these securities.
Due to a clerical error, the Reporting Person's Form 3 which previously reported the holding of these shares understated his total by one (1) share.